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SUZUKI S et al. In the database, uric acid measurements were available for 7,551 patients. To eliminate the effects of medication for hyperuricemia, including uricosuric drugs and inhibitors of xanthine oxidase, we excluded patients on these medications (n=396). Consequently, the remaining 7,155 patients comprised the present subject group.
Data Collection
In each patient, after obtaining an electrocardiogram and chest X-ray, the cardiovascular status was evaluated using echocardiography, an exercise test, 24-h Holter recordings and blood laboratory data from the initial visit, according to the attending physicians. From the database, the following information was collected: (1) patient data, including gender, age, height and weight; (2) cardiovascular disease type, including congestive heart failure, valvular heart disease, myocardial infarction, hypertrophic and dilated cardiomyopathy and history of a disabling cerebral infarction or transient ischemic attack (TIA); (3) cardiovascular risk factors, including hypertension (use of anti-hypertensive agents, systolic blood pressure ≥140 mmHg, or diastolic blood pressure ≥90 mmHg on admission), diabetes mellitus (use of oral hypoglycemic agents or insulin, or glycosylated hemoglobin ≥6.5% (Japanese Diabetes Society value), low high-density lipoprotein (HDL) cholesterolemia (use of statin or serum HDL cholesterol <40 mg/dl) and a history of cerebral infarction or TIA; (4) laboratory data, including serum uric acid and serum creatinine (SCr); and (5) use of medications, including diuretics and renin-angiotensin system (RAS) inhibitors. The body mass index was calculated as weight in kilograms divided by height in meters squared. Estimated glomerular filtration rate (eGFR) was calculated using the new Japanese coefficient for the modified isotope dilution mass spectrometry (IDMS)-traceable 4- 
Definition of AF
In the present study, AF was diagnosed on electrocardiography, including 12-lead surface electrocardiograms and 24-h Holter recordings at the initial visit. It was also diagnosed on any medical history of AF from referring physicians.
Statistical Analysis
All analyses were performed using SPSS version 19.0 (SPSS, Chicago, IL, USA) for Windows (Microsoft, Redmond, WA, USA). Statistical significance was set at P<0.05. Because serum uric acid level differs substantially between genders, results were analyzed separately. 27 Simple linear regression analysis was used to observe the relationship between serum uric acid and other clinical variables in men and women. Next, patients were divided according to sex-specific uric acid tertiles, and crude prevalence rates of AF were calculated for each tertile. Differences in AF prevalence across the uric acid tertiles were examined using trend tests. Thereafter, logistic regression analysis was performed with non-adjusted and adjusted models comparing the highest and middle tertile of uric acid to the lowest one from both sexes. In the adjusted model, the effect of each uric acid tertile was adjusted for age, eGFR, body mass index, presence of hypertension, diabetes mellitus, low HDL cholesterolemia, heart failure, organic cardiac disease and history of cerebral infarction or TIA, and the use of any diuretics or RAS inhibitors.
Ethics
The ethics committee at the Cardiovascular Institute granted permission for this study and all the patients gave written informed consent.
Results

Subject Characteristics
Subject characteristics are listed in Data given as median ± SD and n (%). eGFR, estimated glomerular filtration rate; HDL, high-density lipoprotein; RAS, renin-angiotensin system; TIA, transient ischemic attack. Uric Acid and Prevalence of AF women. Table 2 lists the results of simple linear regression analysis, in which a decrease in eGFR, increase in body mass index, presence of hypertension, low HDL cholesterolemia, heart failure, organic cardiac disease and use of diuretics were significantly associated with an increase in serum uric acid both in men and women (all P<0.001, except for 0.012 for heart failure in men). In contrast, age and diabetes negatively correlated with serum uric acid in men, while the reverse was true for the women. Unexpectedly, the use of RAS inhibitors was associated with an increase in serum uric acid in both sexes.
Uric Acid Tertile Thresholds
In the present subjects, thresholds dividing the first and second, and second and third serum uric acid tertiles were 5.5 and 6.6 mg/dl, respectively, in men (numbers of patients in the first, second and third uric acid tertiles were 1,459, 1,464 and 1,489, respectively). Similarly, thresholds dividing the serum uric acid tertiles in women were 4.2 and 5.1 mg/dl, respectively (numbers of patients in the first, second and third uric acid tertiles were 954, 893 and 896, respectively).
Impact of Uric Acid on AF Prevalence
The prevalence of AF was 18.4% in men and 11.7% in women ( Table 3) . In men, according to the uric acid tertiles, the prevalence of AF significantly increased from 16.4% in the low tertile to 17.1% and 21.6% in the middle and high tertiles, respectively (P for trend, <0.001). Similarly, in women, the prevalence of AF significantly increased from 6.5% in the low to 9.9% and 19.0% in the middle and high tertiles, respectively (P for trend, <0.001).
These clear associations between uric acid and AF were also seen on logistic regression analysis with the non-adjusted model, in which the odds ratio (OR) and 95% confidence interval (95%CI) of the high tertile were 1.408 (1.169-1.695) and 3.368 (2.478-4.578) in men and women, respectively, as compared to the low tertiles. After adjustment for clinical covariates, including age, eGFR, body mass index, hypertension, diabetes mellitus, low HDL cholesterolemia, heart failure, organic cardiac disease and history of cerebral infarction or TIA and use of diuretics or RAS inhibitors, the association remained independent in women (OR, 1.888; 95%CI: 1.278-2.790), but not in men (OR, 1.176; 95%CI: 0.935-1.478).
Discussion
In the present study with patients from a single cardiovascular hospital, the serum uric acid level was apparently associated with AF in both men and women, and the association remained independent in women even after adjustment for various clinical characteristics. The association between uric acid and AF has been reported only in a recent, small study. 22 In the present study, we analyzed a relatively large cohort.
Uric acid has been shown to be a powerful antioxidant and a scavenger of singlet oxygen and radicals. 28 Therefore, it seems to be contradictory that the serum uric acid level is OR in adjusted model was adjusted for age, eGFR, body mass index, hypertension, diabetes mellitus, low HDL cholesterolemia, use of diuretics and RAS, heart failure, organic cardiac disease and history of cerebral infarction/TIA. AF, atrial fibrillation; OR, odds ratio; CI, confidence interval. Other abbreviations see in Table 1 .
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closely associated with various kinds of cardiovascular risk factors, including being male, 16 obesity, 17 hypertension 18 and a decline in renal function. 21 Similar results were obtained in the present study, in which the serum uric acid level was significantly associated with these clinical conditions. The contradictory association between uric acid and cardiovascular risk factors, however, might be possible because serum uric acid level is, at least in part, passively increased by the existence of various cardiovascular risk factors. First, serum uric acid is higher in men 18 and postmenopausal women because estrogen is known to be uricosuric. 29 Second, hyperuricemia frequently occurs in obese subjects with insulin resistance, because insulin stimulates sodium and urate reabsorption in the proximal tubule. 30 Third, serum uric acid is frequently increased in hypertension, presumably because of the decrease in renal blood flow, which stimulates urate reabsorption. 20 Finally, increased uric acid is closely associated with chronic kidney disease as a result of the decrease in renal urate excretion. Therefore, given the close association of AF with male gender, obesity, hypertension and a decline in renal function, 1,12-17 the apparent association between serum uric acid and AF prevalence in the present entire subject group might be explained by a potential surrogate marker effect representing an accumulation of the risks for AF. There still remains the possibility, however, that uric acid might actively affect AF prevalence. One possibility is an indirect mechanism, whereby uric acid activates confounding factors that directly cause AF. Recent studies have indicated that uric acid has a direct effect on smooth muscle cell proliferation, 31 endothelial dysfunction and decreased nitric oxide production, 32,33 as well as local activation of the RAS. 34 Consequently, these uric acid-associated pathogens would lead to the promotion or exacerbation of various comorbidities, including hypertension 35 and chronic kidney disease, 36-38 and the adverse effects of uric acid on these comorbidities might indirectly increase the potential risks for AF development. Another possible explanation would be direct mechanisms via inflammation. 39, 40 Several recent studies have reported that the serum uric acid level is closely associated with increasing of inflammatory markers, including C-reactive protein, 41,42 which strongly predicts future development of AF. 40 The present results also suggest that uric acid has genderspecific, independent effects on AF prevalence in women, because the association remained even after adjustment for comorbidities in women, but not in men. Interestingly, several previous studies have noted that the relative risks or OR for serum uric acid regarding development of hypertension 35 or renal disease, 36-38 were remarkably higher in women than in men, which was very similar to the present results. Although several studies have noted that the mechanism for the gender difference might be, at least in part, linked to menopause, it remains a matter for further discussion.
Study Limitations
The present study had several limitations. First, because it was a cross-sectional study, it remains unclear whether an elevated uric acid level is a cause or a consequence of AF. Therefore, the results should be confirmed in prospective cohort studies. Second, the subject group was limited to patients visiting a single cardiovascular hospital in an urban city in Japan, therefore the results cannot be extrapolated to the general population. Therefore, the present results need to be re-examined in population-based studies. Third, in the present study, AF was diagnosed by medical history and clinical examination, including electrocardiogram and Holter recording. This method is well known to underestimate AF prevalence, because of its neglecting of asymptomatic AF. 43 Last, the present study did not include data involving menopause, which might affect the uric acid level in women. 29 
Conclusions
Among patients visiting a cardiovascular hospital, the serum uric acid level was significantly associated with crude AF prevalence in both men and women, suggesting the compounding link between uric acid and AF via various cardiovascular risk factors affecting AF. At the same time, even after adjustment using the well-known cardiovascular risk factors, the effect of serum uric acid level on AF remained independent in women, but not in men, suggesting a gender-specific linking mechanism. These results emphasize the need for further prospective studies.
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